Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 3, 2010, Pages 463-468

  Woon, Puay San ^a   Chia, Ming Ying ^a   Chan, Wai Yen ^a   Sim, Kang ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

Neurocognitive; Psychopathology; Psychosocial functioning; Quality of life; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; ASIAN; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; VERBAL MEMORY; WORKING MEMORY;

ADULT; ASIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC;

EID: 77949658975     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.01.014     Document Type: Article

References (61)

1. Addington J., Saeedi H., Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res 2005, 78:35-43.
2. Aki H., Tomotake M., Kaneda Y., Iga J., Kinouchi S., Shibuya-Tayoshi S., et al. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 2008, 158:19-25.
3. Aksaray G., Oflu S., KaptanoSǧlu C., Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1217-1219.
4. Alptekin K., Akvardar Y., Kivircik Akdede B.B., Dumlu K., Işik D., Pirinçci F., et al. Is quality of life associated with cognitive impairment in schizophrenia?. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:239-244.
5. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, American Psychiatric Press, Washington, DC. 4th ed.
6. Awad A.G., Voruganti L.N. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull 2000, 26:557-564.
7. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.
8. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 2006, 163:418-425.
9. Bowie C.R., Leung W.W., Reichenberg A., McClure A.A., Patterson T.L., Heaton R.K., et al. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry 2008, 63:505-511.
10. Brekke J.S., Kohrt B., Green M.F. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr Bull 2001, 27:697-708.
11. Brissos S., Dias V.V., Carita A.I., Martinez-Arán A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res 2008, 160:55-62.
12. Browne S., Clarke M., Gervin M., Waddington J.L., Larkin C., O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000, 176:173-176.
13. Caron J., Mercier C., Diaz P., Martin A. Socio-demographic and clinical predictors of quality of life on patients with schizophrenia or schizo-affective disorder. Psychiatry Res 2005, 137:203-213.
14. Dossa P.A. Quality of life: individualism or holism? A critical review of the literature. Int J Rehabil Res 1989, 12:121-136.
15. Eack S.M., Newhill C.E. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007, 33:1225-1237.
16. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
17. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
18. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001, 103:387-392.
19. Folsom D.P., Depp C., Palmer B.W., Mausbach B.T., Golshan S., Fellows I., et al. Physical and mental health-related quality of life among older people with schizophrenia. Schizophr Res 2009, 108:207-213.
20. Fujii D.E., Wylie A.M., Nathan J.H. Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophr Res 2004, 69:67-73.
21. Galletly C.A., Clark C.R., McFarlane A.C., Weber D.L. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 1997, 72:161-166.
22. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996, 153:321-330.
23. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull 2000, 26:119-136.
24. Hasson-Ohayon I., Kravetz S., Roe D., David A.S., Weiser M. Insight into psychosis and quality of life. Compr Psychiatry 2006, 47:265-269.
25. Heaton R.K., Chelune G.J., Lehman R.A. Using neuropsychological and personality tests to assess the likelihood of patient employment. J Nerv Ment Dis 1978, 166:408-416.
26. Herrman H., Hawthorne G., Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol 2002, 37:510-518.
27. Heslegrave R.J., Awad A.G., Voruganti L.N.P. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997, 22:235-243.
28. Ho B.C., Nopoulos P., Flaum M., Arndt S., Andreasen N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998, 155:1196-1201.
29. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004, 65:932-939.
30. Hofer A., Baumgartner S., Edlinger M., Hummer M., Kemmler G., Rettenbacher M.A., et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry 2005, 20:386-394.
31. Hofer A., Rettenbacher M.A., Widschwendter C.G., Kemmler G., Hummer M., Fleischhacker W.W. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 2006, 256:246-255.
32. Huppert J.D., Weiss K.A., Lim R., Pratt S., Smith T.E. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 2001, 51:171-180.
33. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
34. Kearns R.A., Taylor S.M., Dear M. Coping and satisfaction among the chronically mentally disabled. Can J Commun Ment Health 1991, 6:13-25.
35. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004, 68:283-297.
36. Kim Y., Sakamoto K., Kamo T., Sakamura Y., Miyaoka H. Insight and clinical correlates in schizophrenia. Compr Psychiatry 1997, 38:117-123.
37. Kovess-Masféty V., Xavier M., Moreno Kustner B., Suchocka A., Sevilla-Dedieu C., Dubuis J., et al. Schizophrenia and quality of life: a one-year follow-up in four EU countries. BMC Psychiatry 2006, 6:39.
38. Lipkovich I.A., Deberdt W., Csernansky J.G., Sabbe B., Keefe R.S., Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24weeks of antipsychotic drug therapy. BMC Psychiatry 2009, 9:44.
39. Lysaker P.H., Clements C.A., Wright D.E., Evans J., Marks K.A. Neurocognitive correlates of helplessness, hopelessness, and well-being in schizophrenia. J Nerv Ment Dis 2001, 189:457-462.
40. McGurk S.R., Moriarty P.J., Harvey P.D., Parrella M., White L., Davis K.L. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophr Res 2000, 42:47-55.
41. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999, 25:233-255.
42. Mercier C., Péladeau N., Tempier R. Age, gender and quality of life in schizophrenia. Community Ment Health J 1998, 34:487-500.
43. Mutsatsa S.H., Joyce E.M., Hutton S.B., Barnes T.R.E. Relationship between insight, cognitive function, social function and symptomatology in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006, 256:356-363.
44. Narvaez J.M., Twamley E.W., McKibbin C.L., Heaton R.K., Patterson T.L. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008, 98:201-208.
45. Packer S., Husted J., Cohen S., Tomlinson G. Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci 1997, 22:231-234.
46. Perlick D.A., Rosenheck R.A., Kaczynski R., Bingham S., Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophr Res 2008, 99:192-199.
47. Preacher K.J., Leonardelli G.J. Calculation for the Sobel test: An interactive calculation tool for mediation tests 2001, accessed on 14 January 2010] Available from: http://people.ku.edu/~preacher/sobel/sobel.htm.
48. Proteau A., Verdoux H., Briand C., Lesage A., Lalonde P., Nicole L., et al. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res 2005, 77:343-353.
49. Ritsner M.S. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Qual Life Res 2007, 16:929-937.
50. Rodriguez-Ferrera S., Vassilas C.A., Haque S. Older people with schizophrenia: a community study in a rural catchment area. Int J Geriatr Psychiatry 2004, 19:1181-1187.
51. Ruggeri M., Nosè M., Bonetto C., Cristofalo D., Lasalvia A., Salvi G., et al. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry 2005, 187:121-130.
52. Salokangas R.K., Honkonen T., Stengård E., Koivisto A.M. To be or not to be married-that is the question of quality of life in men with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2001, 36:381-390.
53. Savilla K., Kettler L., Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry 2008, 42:496-504.
54. Sim K., Mahendran R., Siris S.G., Heckers S., Chong S.A. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 2004, 129:141-147.
55. Sobel M.E. Asymptotic confidence intervals for indirect effects in structural equation models. Sociological Methodology 1982, 290-312. American Sociological Association, Washington DC. S. Leinhardt (Ed.).
56. Strejilevich S.A., Palatnik A., Avila R., Bustin J., Cassone J., Figueroa S., et al. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Res 2005, 133:277-280.
57. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998, 28:551-558. The WHOQOL Group.
58. Velligan D.I., Mahurin R.K., Diamond P.L., Hazleton B.C., Eckert S.L., Miller A.L. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res 1997, 25:21-31.
59. Voruganti L., Heslegrave R., Awad A.G., Seeman M.V. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998, 28:165-172.
60. Wilkinson G. The Wide Range Achievement Test: administration manual 1993, Jastak Associates, Inc, Wilmington, DE.
61. Yeung F.K., Chan S.H. Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong. Qual Life Res 2006, 15:1459-1469.